Trestolone 100

Trestolone Enanthate — MENT Long-Ester by Dragon Pharma

Trestolone Enanthate (MENT Enanthate) is Dragon Pharma's long-ester formulation of Trestolone (7α-methyl-19-nortestosterone) at 100mg/ml — the same active compound as MENT 50 (Acetate) with the Enanthate ester replacing the Acetate ester, extending the half-life from ~8 hours to ~7-10 days and reducing injection frequency from daily to twice weekly. For full compound background — anabolic ratio 2,300, androgenic ratio 650, contraceptive history, no testosterone base requirement, and 7α-methyl-estradiol aromatisation — see the MENT 50 page. This page focuses on what the ester change means in practice.

Also searched as: Trestolone Enanthate, MENT Enanthate, Trestolone 100 Enanthate, MENT long ester Dragon Pharma.

The Ester Difference — What Enanthate Changes vs Acetate

The compound is identical; the ester determines the practical experience of using it:

Who Should Choose Enanthate vs Acetate

The ester choice should be driven by practical protocol requirements:

• Choose Trestolone Enanthate if: you are running a planned, structured cycle of defined length (10-16 weeks) where twice-weekly injection is preferred; you have prior Trestolone experience from MENT 50 and understand your estrogen management requirements; you want the stable blood level profile of a long-ester compound rather than daily injection peaks and troughs; your cycle includes other Enanthate-ester compounds (Testosterone Enanthate, Masteron Enanthate, Primobolan Enanthate) making twice-weekly injection-day coordination straightforward
• Choose MENT 50 (Acetate) if: this is your first Trestolone cycle and you want daily dosing flexibility to quickly reduce dose or stop if side effects emerge — the Acetate's short half-life means a dose can be skipped and blood levels drop within 24 hours; you prefer the dose control that short-ester daily injection provides; or you are running a short cycle (4-8 weeks) where the Enanthate's 3-4 week ramp to steady-state takes up too large a proportion of the cycle length

Blood Level Curve — The Long-Ester Profile

Understanding the Enanthate blood level profile is essential for managing Trestolone's specific challenges:

• After the first injection, Trestolone Enanthate levels build gradually — meaningful blood levels are reached by day 3-5, with steady state achieved around weeks 3-4 of twice-weekly dosing
• This ramp-up phase means side effects also emerge gradually — estrogenic effects (from 7α-methyl-estradiol) and progestin effects build over 2-4 weeks rather than appearing immediately as with Acetate
• Critically: the slow ramp also means that estrogen management problems (gynecomastia development) can be insidious with Enanthate — it may not be obvious that estrogen is becoming problematic until it is well-established. Starting AI management from injection day 1 is advisable with Enanthate
• After the last injection, blood levels decline over 2-3 weeks — PCT should not begin until 14-21 days post last injection to avoid starting PCT while active compound is still present

Dosage and Administration

Note that 200mg/week Trestolone Enanthate delivers approximately 200mg of Trestolone with no ester mass deduction — but given the anabolic ratio of 2,300 vs testosterone's 100, this represents an anabolic equivalent well above equivalent testosterone doses. Conservative starting dose is warranted. Estrogen management with Arimidex or Aromasin from day 1 — 7α-methyl-estradiol aromatisation requires AI just as with Acetate, though standard E2 blood tests do not detect 7α-Me-E2 specifically.